194 related articles for article (PubMed ID: 33840010)
21. Local and metastatic curative radiotherapy in patients with de novo oligometastatic prostate cancer.
Reverberi C; Massaro M; Osti MF; Anzellini D; Marinelli L; Montalto A; De Sanctis V; Valeriani M
Sci Rep; 2020 Oct; 10(1):17471. PubMed ID: 33060732
[TBL] [Abstract][Full Text] [Related]
22. Temporality and Patterns of Metastatic Recurrence in Node-Positive Breast Cancer Following Trimodality Therapy: Opportunity for Improved Oligometastases Detection and Salvage Local Therapy.
Ariani R; Hwang L; Maliglig AM; Ragab O; Ye JC
Am J Clin Oncol; 2022 Feb; 45(2):88-94. PubMed ID: 34991105
[TBL] [Abstract][Full Text] [Related]
23. Outcome of postmastectomy radiotherapy after primary systemic treatment in patients with clinical T1-2N1 breast cancer.
Cao L; Ou D; Shen KW; Cai G; Cai R; Xu F; Zhao SG; Xu C; Grellier Adedjouma N; Kirova YM; Chen JY
Cancer Radiother; 2018 Feb; 22(1):38-44. PubMed ID: 29306555
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive locoregional treatment and systemic therapy for postmastectomy isolated locoregional recurrence.
Kuo SH; Huang CS; Kuo WH; Cheng AL; Chang KJ; Chia-Hsien Cheng J
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1456-64. PubMed ID: 18692329
[TBL] [Abstract][Full Text] [Related]
25. Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1).
Imoto S; Wang K; Bi XW; Liu G; Im YH; Im SA; Sim SH; Ueno T; Futamura M; Toi M; Fujiwara Y; Ahn SG; Lee JE; Park YH; Takao S; Oba MS; Kitagawa Y; Nishiyama M
Breast Cancer; 2023 May; 30(3):412-423. PubMed ID: 36689066
[TBL] [Abstract][Full Text] [Related]
26. Association between the 21-gene recurrence score and isolated locoregional recurrence in stage I-II, hormone receptor-positive breast cancer.
Yang DD; Buscariollo DL; Cronin AM; Weng S; Hughes ME; Bleicher RJ; Cohen AL; Javid SH; Edge SB; Moy B; Niland JC; Wolff AC; Hassett MJ; Punglia RS
Radiat Oncol; 2020 Aug; 15(1):198. PubMed ID: 32799886
[TBL] [Abstract][Full Text] [Related]
27. Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial.
Aebi S; Gelber S; Anderson SJ; Láng I; Robidoux A; Martín M; Nortier JW; Paterson AH; Rimawi MF; Cañada JM; Thürlimann B; Murray E; Mamounas EP; Geyer CE; Price KN; Coates AS; Gelber RD; Rastogi P; Wolmark N; Wapnir IL;
Lancet Oncol; 2014 Feb; 15(2):156-63. PubMed ID: 24439313
[TBL] [Abstract][Full Text] [Related]
28. Clinical outcomes of curative-intent multimodal management of chemorefractory nonmetastatic inflammatory breast cancer.
Loap P; Nicaise B; Laki F; Loirat D; Pierga JY; Fourquet A; Kirova Y
Strahlenther Onkol; 2023 Jan; 199(1):30-37. PubMed ID: 35648170
[TBL] [Abstract][Full Text] [Related]
29. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
[TBL] [Abstract][Full Text] [Related]
30. Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.
White R; Dinneen T; Makris A
Radiat Oncol; 2016 Jul; 11():93. PubMed ID: 27457764
[TBL] [Abstract][Full Text] [Related]
31. Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial.
Trovo M; Furlan C; Polesel J; Fiorica F; Arcangeli S; Giaj-Levra N; Alongi F; Del Conte A; Militello L; Muraro E; Martorelli D; Spazzapan S; Berretta M
Radiother Oncol; 2018 Jan; 126(1):177-180. PubMed ID: 28943046
[TBL] [Abstract][Full Text] [Related]
32. A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases.
Fumagalli I; Bibault JE; Dewas S; Kramar A; Mirabel X; Prevost B; Lacornerie T; Jerraya H; Lartigau E
Radiat Oncol; 2012 Sep; 7():164. PubMed ID: 23014094
[TBL] [Abstract][Full Text] [Related]
33. Ten-year outcome after combined modality therapy for inflammatory breast cancer.
Harris EE; Schultz D; Bertsch H; Fox K; Glick J; Solin LJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1200-8. PubMed ID: 12654428
[TBL] [Abstract][Full Text] [Related]
34. Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse.
Haffty BG; Reiss M; Beinfield M; Fischer D; Ward B; McKhann C
J Clin Oncol; 1996 Jan; 14(1):52-7. PubMed ID: 8558220
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic Characteristics of Oligometastases from Esophageal Cancer and Long-Term Outcomes of Resection.
Ohkura Y; Shindoh J; Ueno M; Iizuka T; Udagawa H
Ann Surg Oncol; 2020 Mar; 27(3):651-659. PubMed ID: 31898096
[TBL] [Abstract][Full Text] [Related]
36. Poor Prognosis After Second Locoregional Recurrences in the CALOR Trial.
Wapnir IL; Gelber S; Anderson SJ; Mamounas EP; Robidoux A; Martín M; Nortier JW; Geyer CE; Paterson AH; Láng I; Price KN; Coates AS; Gelber RD; Rastogi P; Regan MM; Wolmark N; Aebi S;
Ann Surg Oncol; 2017 Feb; 24(2):398-406. PubMed ID: 27663567
[TBL] [Abstract][Full Text] [Related]
37. The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program.
Elias AD; Ibrahim J; Richardson P; Avigan D; Joyce R; Reich E; McCauley M; Wheeler C; Frei E
Biol Blood Marrow Transplant; 2002; 8(4):198-205. PubMed ID: 12017145
[TBL] [Abstract][Full Text] [Related]
38. Oligometastatic breast cancer treated with hypofractionated stereotactic radiotherapy: Some patients survive longer than a decade.
Milano MT; Katz AW; Zhang H; Huggins CF; Aujla KS; Okunieff P
Radiother Oncol; 2019 Feb; 131():45-51. PubMed ID: 30773186
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
Sanpaolo P; Barbieri V; Genovesi D
Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
[TBL] [Abstract][Full Text] [Related]
40. Local salvage therapy for late (≥2 years) metastatic and local relapse of renal cell cancer is a potentially curative treatment irrespective of the site of recurrence.
Grüllich C; Vallet S; Hecht C; Duensing S; Hadaschik B; Jäger D; Hohenfellner M; Pahernik S
Urol Oncol; 2016 May; 34(5):238.e9-17. PubMed ID: 26739671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
